clinical pharmacology regulatory sciences in drug development and precision medicine
Published 3 years ago • 3K plays • Length 37:46Download video MP4
Download video MP3
Similar videos
-
3:41
the frontiers of clinical pharmacology and drug development
-
52:11
overview: clinical pharmacology considerations for food effect studies
-
21:10
office of clinical pharmacology (ocp): drugs and biologics - bioanalysis 2020
-
56:25
overview: clinical pharmacology considerations for neonatal studies
-
30:51
drug development and regulation in the age of precision medicine
-
3:41
fda cder regulatory science: patient-focused drug development
-
26:05
the finalized bioanalytical method validation guidance: what’s new for ndas and blas – june 17, 2019
-
0:30
what is fda’s role in regulating drugs? (30 seconds)
-
48:50
getting the best dose: the clinical pharmacology studies that help achieve this goal
-
6:15:55
pharmaceutical science and clinical pharmacology advisory committee meeting (pscp)
-
22:19
midd training module 3 – pediatric drug development considerations
-
19:10
product-specific guidances for complex generic drugs
-
1:07:29
presenting clinical pharmacology information in prescription drug labeling – jun. 19, 2017
-
25:07
office of clinical pharmacology (ocp): biosimilars - bioanalysis 2020
-
35:06
oncology drug development in the era of precision medicine: fda perspective
-
46:50
application of pharmacogenomics in drug development, regulatory review and clinical practice
-
3:46:10
an introduction to the cder quantitative medicine center of excellence
-
2:54
what is precision medicine?
-
30:05
13 "regulatory considerations for the next generation of medicines" michael pacanowski